Aberrant promoter methylation of FBLN-3 gene and clinicopathological significance in non-small cell lung carcinoma
Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, 210002, China
Received 3 July 2009; received in revised form 5 October 2009; accepted 9 October 2009. published online 13 November 2009.
PII: S0169-5002(09)00537-6
doi:10.1016/j.lungcan.2009.10.009
© 2009 Elsevier Ireland Ltd. All rights reserved.
http://s7.addthis.com/js/250/addthis_widget.js#pub=xa-4b1d65bd00983246Access this article on
SciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.